MarketLens
Sign Up

Boston Scientific Insiders Bet on a Long-Term Rebound Amidst Near-Term Headwinds

1 months ago
SHARE THIS ON:

Boston Scientific Insiders Bet on a Long-Term Rebound Amidst Near-Term Headwinds

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Related Articles

Category

You may also like

Stock News6 days ago

3 CEOs Are Buying Millions of Dollars of Their Beaten-Down Stocks

Three CEOs are buying millions of dollars of their beaten-down stocks, signaling insider confidence amid declines. Insider purchases by top executives can offer notable signals for investors.
Stock News4 weeks ago

Brokers Suggest Investing in Boston Scientific (BSX): Read This Before Placing a Bet

Boston Scientific (BSX) is under analyst scrutiny as brokerage recommendations may influence its stock price. Investors should weigh these ratings carefully before acting, as media coverage of rating ...
Stock News1 months ago

Boston Scientific CEO Mahoney Buys More Than 200k Shares for $10 Million. What Does This Mean for Investors in 2026?

Boston Scientific CEO Michael Mahoney bought ~200,000 shares for ~$10.0 million on August 3, 2026, at $48.34, raising his total equity holdings by 13%. The insider purchase signals management confiden...

Breaking News

View All →

Top Headlines

View More →
Stock News56 minutes ago

Palantir Technologies Showcases Sovereign AI Wins With NVIDIA, Cisco and FAA

Stock News1 hour ago

Here's Why Meta Platforms (META) Fell More Than Broader Market

Stock News1 hour ago

IBM (IBM) Dips More Than Broader Market: What You Should Know

Stock News1 hour ago

Tesla (TSLA) Falls More Steeply Than Broader Market: What Investors Need to Know

Stock News1 hour ago

Nvidia Returned $26 Billion to Shareholders Last Quarter Alone. Here's What That Buys You as an Investor.